Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Do Not Be Surprised By Corporate Responsibility Standards - FDA Warns

This article was originally published in The Tan Sheet

Executive Summary

The standards FDA is reviewing for prosecuting corporate officers deemed responsible for violations they reasonably could have prevented should not catch firms by surprise, according to FDA's litigation chief
Advertisement

Related Content

J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics
J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics
J&J Woes, Pharma Switch Outlook Lead "The Tan Sheet" 2010 Topics
Misdemeanor Charges Drive FDA's Park Doctrine Enforcement
Misdemeanor Charges Drive FDA's Park Doctrine Enforcement
Misdemeanor Charges Drive FDA's Park Doctrine Enforcement
FDA Agrees With GAO Recommendations To Give Prosecutions Higher Priority
FDA Agrees With GAO Recommendations To Give Prosecutions Higher Priority
GlaxoSmithKline Hires Former FDA Top Lawyer Dan Troy As General Counsel

Topics

Advertisement
UsernamePublicRestriction

Register

PS104175

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel